News Conference News TCT 2016 Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence Todd Neale November 01, 2016
News Conference News TVT 2016 Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance Shelley Wood June 20, 2016
News Conference News TVT 2016 Teenage TAVR: Should Practice Forge on While Guidelines Grow Up? Michael O'Riordan June 20, 2016
News Conference News TVT 2016 Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY Michael O'Riordan June 18, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Conference News EuroPCR 2016 ‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices Caitlin E. Cox May 17, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015
News Conference News TCT 2015 MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions October 14, 2015
News Conference News ACC 2015 Follow-up TAVR Studies Reassure About Valve Durability, Outcomes Todd Neale March 15, 2015
News Conference News TCT 2014 Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk September 13, 2014
News Conference News ACC 2013 ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting L.A. McKeown March 14, 2013
News Conference News ACC 2013 PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished Yael L. Maxwell March 11, 2013
News Conference News TCT 2012 Review of TAVR Use Offers Significant Advances, Positive Outcomes October 22, 2012
News Conference News Complications After TAVR: Manageable, But Important to Consider November 09, 2011